• Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Executives Depart Cassava, Maker of Disputed Alzheimer’s Drug

The chief executive and a lead scientist stepped down weeks after a federal grand jury filed fraud charges against a research collaborator.

Teddy Rosenbluth
Author: Teddy Rosenbluth

Written by

Teddy Rosenbluth

in

Appointments and Executive Changes, Cassava Sciences Inc, City College of New York, Clinical Trials, Drugs (Pharmaceuticals), Falsification of Data, Research, Securities and Commodities Violations
←Biden’s Student Loan Repayment Plan Blocked by Federal Appeals Court
Imagery Of A Bloodied Trump And Calls To ‘Fight’ Are Everywhere At The RNC→

More posts

  • Kacey Musgraves on “Middle of Nowhere”

  • Man arrested for suspected arson after fire at packed LGBT+ club near Milton Keynes

  • I’m Thinking Of A Movie, TV Show, And Celeb — Can You Guess Them With As Few Clues As Possible?

  • Only A True Mind Reader Can Guess The Movie, TV Show, And Celeb I’m Thinking Of From The First Clue

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube